InMed Pharmaceuticals Inc. (INM) Social Stream



InMed Pharmaceuticals Inc. (INM): $4.40

0.26 (+6.28%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

Add INM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#166 of 335

in industry

INMED PHARMACEUTICALS INC (INM) Price Targets From Analysts

Use the tables below to see what analysts covering INMED PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-29 1 $9 $9 $9 $0.37 2332.43%
2021-11-19 1 $7.5 $7.5 $7.5 $0.37 1927.03%
2021-11-29 1 $150 $150 $150 $0.37 40440.54%
2022-02-15 2 $6 $6 $6 $0.37 1521.62%
2022-05-16 2 $150 $20 $85 $0.37 22872.97%
2023-01-09 2 $45 $45 $45 $0.37 12062.16%
NA 1 $NA $NA $NA $0.37 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target


Over the past 18 months, INM's average price target has gone up $33.5.

Over the past 0 secs, INM's average upside potential has been 2,562.72%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-09 1 45 45 45 1.69 2562.72%
2023-01-09 2 45 45 45 1.69 2562.72%

INM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 14 months, INM's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how INMED PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 19.81% of that group.
  • INMED PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1187.85% of all US stocks.
  • INMED PHARMACEUTICALS INC's variance in analysts' estimates is lower than -110.48% of Healthcare stocks.
  • INM has a higher average analyst price target than 475.97% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, PTPI, GRI, and LIPO are the three stocks most similar to INMED PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for INM? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!